These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35119176)

  • 1. Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause - the Cardiogenic Shock Score.
    Beer BN; Jentzer JC; Weimann J; Dabboura S; Yan I; Sundermeyer J; Kirchhof P; Blankenberg S; Schrage B; Westermann D
    Eur J Heart Fail; 2022 Apr; 24(4):657-667. PubMed ID: 35119176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support.
    Chatzis G; Markus B; Syntila S; Waechter C; Luesebrink U; Ahrens H; Divchev D; Schieffer B; Karatolios K
    J Interv Cardiol; 2021; 2021():8843935. PubMed ID: 33536855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
    Pöss J; Köster J; Fuernau G; Eitel I; de Waha S; Ouarrak T; Lassus J; Harjola VP; Zeymer U; Thiele H; Desch S
    J Am Coll Cardiol; 2017 Apr; 69(15):1913-1920. PubMed ID: 28408020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMPARISON OF THE PREDICTIVE PERFORMANCE OF CARDIOGENIC SHOCK SCORES IN A REAL-WORLD LATIN AMERICA COUNTRY.
    Ortega-Hernández J; González-Pacheco H; Nieto RG; Araiza-Garaygordobil D; Lara-Martínez DS; De La Cruz JLB; Mendoza-García S; Altamirano-Castillo A; Orozco ÁM; Herrera LAB; Hernández-Montfort J; Aguilar-Montaño KM; Uriona LAS; López JÁFM; Loría CAL; Arias-Mendoza A
    Shock; 2023 Apr; 59(4):576-582. PubMed ID: 36821419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic performance of the IABP-SHOCK II Risk Score among cardiogenic shock subtypes in the critical care cardiology trials network registry.
    Alviar CL; Li BK; Keller NM; Bohula-May E; Barnett C; Berg DD; Burke JA; Chaudhry SP; Daniels LB; DeFilippis AP; Gerber D; Horowitz J; Jentzer JC; Katrapati P; Keeley E; Lawler PR; Park JG; Sinha SS; Snell J; Solomon MA; Teuteberg J; Katz JN; van Diepen S; Morrow DA;
    Am Heart J; 2024 Apr; 270():1-12. PubMed ID: 38190931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
    Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Hemodynamic Response to Intra-Aortic Balloon Counterpulsation in Patients With Cardiogenic Shock Resulting from Acute Myocardial Infarction Versus Acute Decompensated Heart Failure.
    Malick W; Fried JA; Masoumi A; Nair A; Zuver A; Huang A; Haythe J; Farr M; Rabbani L; Karmpaliotis D; Kirtane AJ; Topkara VK; Takeda K; Garan AR
    Am J Cardiol; 2019 Dec; 124(12):1947-1953. PubMed ID: 31648782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
    Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
    Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Prognostic Impact of IABP-SHOCK II Scores According to Treatment Strategy in Cardiogenic Shock Complicating Acute Coronary Syndrome: From the RESCUE Registry.
    Kim BS; Jang WJ; Choi KH; Kim SH; Yu CW; Jeong JO; Lee HJ; Gwon HC; Kim HJ; Yang JH
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276062
    [No Abstract]   [Full Text] [Related]  

  • 12. External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients.
    Rivas-Lasarte M; Sans-Roselló J; Collado-Lledó E; González-Fernández V; Noriega FJ; Hernández-Pérez FJ; Fernández-Martínez J; Ariza A; Lidón RM; Viana-Tejedor A; Segovia-Cubero J; Harjola VP; Lassus J; Thiele H; Sionis A
    Eur Heart J Acute Cardiovasc Care; 2020 Jan; ():. PubMed ID: 32004078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
    Ceglarek U; Schellong P; Rosolowski M; Scholz M; Willenberg A; Kratzsch J; Zeymer U; Fuernau G; de Waha-Thiele S; Büttner P; Jobs A; Freund A; Desch S; Feistritzer HJ; Isermann B; Thiery J; Pöss J; Thiele H
    Eur Heart J; 2021 Jun; 42(24):2344-2352. PubMed ID: 33647946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of intra-aortic balloon pump for myocardial infarction in patients with or without cardiogenic shock: a meta-analysis and systematic review.
    Zheng XY; Wang Y; Chen Y; Wang X; Chen L; Li J; Zheng ZG
    BMC Cardiovasc Disord; 2016 Jul; 16(1):148. PubMed ID: 27391391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gender difference in efficacy of intra-aortic balloon pump in acute myocardial infarction patients complicating with cardiogenic shock].
    Guo C; Teng HB; Zhang J; Li J; Xu HB; Wang XY; Yuan JS; Yang WX; Hu FH; Wu Y; Qiao SB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):675-681. PubMed ID: 32847324
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.
    Karami M; Eriksen E; Ouweneel DM; Claessen BE; Vis MM; Baan J; Beijk M; Packer EJS; Sjauw KD; Engstrom A; Vlaar A; Lagrand WK; Henriques JPS
    Eur Heart J Acute Cardiovasc Care; 2021 Dec; 10(9):1009-1015. PubMed ID: 34327527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients.
    Schäfer A; Werner N; Burkhoff D; Sieweke JT; Zietzer A; Masyuk M; Junker Udesen NL; Westenfeld R; Møller JE
    Front Cardiovasc Med; 2020; 7():74. PubMed ID: 32478095
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity.
    Jentzer JC; van Diepen S; Henry TD; Baran DA; Barsness GW; Holmes DR
    Catheter Cardiovasc Interv; 2022 Feb; 99(2):293-304. PubMed ID: 34047486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.